Hospitals and Health Care
Providers

Contacts
Thomas Beimers,Changes in government policy, regulation, and themarket are transforming hospital operations and healthcare delivery – constantly adding new challenges to an
already demanding environment.
We know how overwhelming it can be trying toeffectively navigate today's regulatory environmentand capitalize on strategic opportunities. Many
members of our team have previously worked in key
positions in both the private and public sectors,
including the U.S. Department of Health and HumanServices (HHS), the Centers for Medicare & Medicaid
Services (CMS), and the Federal Trade Commission(FTC). We leverage our previous experience as top
government officials in regulatory and policy agencies.
And we leverage our long record of advising worldclass clients in the hospital and health care delivery
sector to anticipate future challenges and propose
creative solutions.
From corporate structure and compliance toconsolidations and transactions, we'll help you stayahead of potential issues, avoid regulatory problems,and execute effectively on your immediate and longterm strategies. Having an in-depth understanding of
the relationship between the government and global
health care marketplace allows us to counsel you
effectively on legal and regulatory issues – and to be
your strategic advisor, litigator, and dealmaker, too.

Minneapolis

Ken Field,
Washington, D.C.

Practices
Pharmaceuticals andBiotechnology
Regulatory
Privacy andCybersecurity
Antitrust andCompetition

Industries
Life Sciences and HealthCareOur health care transactions team leads the nation in
the number of complex hospital, academic medical
centers, and health system transactions it has handled.
Combining our technical and industry knowledge
enables us to understand your objectives, plan for thepositions likely to be taken by other parties, and help
you develop the best deal structure and strategy.

Representative experience
Howard University on a management services
agreement with Adventist HealthCare to build a new
replacement hospital as part of their overall strategy toserve the health care needs of the community andregion.
Vanderbilt University on transfer of its medical center,dozens of ancillary businesses and sites, and a 50hospital affiliated network to a newly formed
independent organization.
St. Louis University on acquisition of St. LouisUniversity Hospital from Tenet Healthcare andcontribution of hospital assets to newly formed joint
venture with SSM Health.
The University of Pennsylvania on its exclusive licenseand collaboration agreement with Novartis for thedevelopment of novel CAR-T therapies.
Fred Hutchinson Cancer Research Center in its initialfounding, investment, licensing, collaboration,
contractual and shareholder matters, and initial public
offering of Juno Therapeutics.
Fred Hutchinson Cancer Research Center in its licenseand collaboration agreements with Faraday
Pharmaceuticals.
A large multi-site hospital system in a series of adverse
audit findings to enhance its financial andadministrative compliance policies and procedures, anddelivered comprehensive research compliance training.

Assist multiple hospitals to establish affiliated research
institutes, advise on federal grant and contract law,draft research policies and agreements, and create
federal regulatory compliance structures.
Draft conflict of interest policies for academic medicalcenters and advise on issues that arise in negotiating
licensing agreements and other commercialarrangements.
Help payers on behalf of provider associations to
influence coverage and reimbursement proposals andresolve coverage and reimbursement challenges.
Hospitals and academic medical centers in matters
involving claims of fraud in connection with federallyfunded programs, including clinical research programs.
Numerous public and private hospitals and academic
medical centers on establishing health care fraud andabuse compliance programs.
Medical centers on HIPAA compliance, policies andprocedures, privacy, and information security. We arealso involved in data breach prevention efforts andsecurity incident investigations.
Advised a national health care company on applicablelaws and regulations for delivery of physician visits andconsultations over the internet.
Advised on various regulatory aspects of international
telemedicine, including cross-border health care, data
privacy, and medical device aspects.
Advising a major hospital on efforts to establish
administrative office locations and clinical researchsites across four continents.
Advised an institution on preparing guidelines for thelaunch of its digital health project in China, addressing
regulatory constraints and proposing measures tomanage regulation.
Conducted audits and facilitated reporting for several
hospital Human Research Protection Programs toassess compliance with FDA and the Office of Human

Research Protections (OHRP) regulations.
American Hospital Association, the Association ofAmerican Colleges, and three individual hospitals onfending off a rule to cut more than US$600m toMedicare providers of outpatient hospital services.

Latest thinking and eventsNews
New FDA clinical trials guidances promote efficient
drug development, innovative designs, diversity
News
Life Sciences Procurement Update: FY2025 NDAA
would change rules of origin for drugs
News
Life Sciences Procurement Update: FY2025 NDAA
would change rules of origin for drugs
News
Life Sciences Procurement Update: Changes to Rules ofOrigin for Drugs in FY 2025 NDAA Senate BillNewsNew French template agreement for clinical trials: more
standardization, less simplification
NewsBreaking News for Breakthrough Devices: CMS
Finalizes Transitional Coverage for Emerging
Technologies Pathway